Published November 17, 2026 | Version v1

Inhibition of the mammalian target of rapamycin (mTOR) as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies - A review of the evidence

Authors/Creators

  • 1. Latina, Italy

Description

mTOR inhibition shows antiepileptogenic effects in tuberous sclerosis mouse models and limited clinical data; evidence remains preclinical and not definitive.

Notes

Articolo originale: https://lifesciencehub.info/en/inhibition-of-the-mammalian-target-of-rapamycin-mtor-as-a-potential-antiepileptogenic-therapy-from.

Files

lsh-article-406-en.pdf

Files (302.7 kB)

Name Size
md5:938dac734c29acfaec6ce881263415fd
302.7 kB Preview Download

Additional details